Mukka Proteins Aims For 1,000 TPD Wet-Waste Processing To Grow Bio-Economy

Market snapshot: Mukka Proteins has announced plans to scale its wet-waste conversion capacity in Bengaluru to 1,000 tonnes per day (TPD) by December 2027 (as stated in the source alert; not independently verified). The circular bio-economy initiative utilizes Black Soldier Fly (BSF) bioconversion technology to process municipal organic waste. This process converts urban wet waste into valuable commercial products, including insect protein, insect oil, compost, and humic acid.

Data Snapshot

• Consolidated Revenue for FY26 stood at ₹1,449.5 crore, registering a growth of 44% Year-on-Year.
• Consolidated EBITDA for FY26 rose by 30.9% Year-on-Year to ₹145.3 crore.
• Consolidated PAT for FY26 increased by 18.7% Year-on-Year to ₹57.1 crore.
• The existing active BSF wet-waste facility in Bengaluru operates at 300 TPD.

What's Changed

• Incremental approval has been secured to expand wet-waste processing from the current 300 TPD up to 1,000 TPD.
• The active wet-waste project has been formally registered under Verra Project ID 5893, allowing progress toward issuing Verified Carbon Units (VCUs).

Key Takeaways

• The capacity expansion significantly increases production volumes of high-value alternative protein derivatives for aquaculture and pet feeds.
• By utilizing Black Soldier Fly bioconversion, the process achieves a massive 80% reduction in raw municipal wet waste volume, creating high-margin circular revenues.
• Verra Registry listing opens a new, pure-margin sustainability revenue stream through certified carbon offsets.
• Strategic alignment with Bengaluru Solid Waste Management Limited (BSWML) guarantees localized raw material feedstock.

SAHI Perspective

Mukka Proteins is successfully executing an asset-light, ESG-driven business transition. Historically reliant on marine-dependent feeds, which are vulnerable to volatile fish catch seasons, the expansion into insect-based protein via BSF technology stabilizes raw material supplies. Transforming cheap municipal organic waste into four key revenue-generating streams (protein meal, lipids, compost, and bio-stimulants) effectively insulates the business from conventional supply chain shocks.

Market Implications

Developing a 1,000 TPD waste processing footprint improves ESG ratings and triggers a valuation re-rating. Standard commodity feed processors typically trade at lower multiples, but transitioning to a certified circular bio-economy platform allows Mukka to trade at premium environmental utility valuation multiples.

Trading Signals

Market Bias: Bullish

Expanding to 1,000 TPD wet-waste capacity, backed by Verra carbon offset registration and robust FY26 financial performance (EBITDA up 30.9% to ₹145.3 crore), provides strong visibility for alternative protein revenue scaling.

Overweight: Alternative Proteins, Organic Waste Processing, Bio-Fertilizers

Underweight: Traditional Marine Agri-feeds

Trigger Factors:

• Phased execution milestones reaching 400 TPD in the coming quarters
• Initial issuance and monetization of Verified Carbon Units under Verra Project ID 5893
• Sustained quarterly margin expansion as high-margin alternative protein products scale up

Time Horizon: Medium-term (3-12 months)

Industry Context

Metropolitan cities like Bengaluru generate thousands of tonnes of municipal solid waste daily, of which over 50% is organic wet waste. Under strict regulatory guidelines on waste processing, specialized biological treatment technologies are rapidly expanding, creating high-growth sectors in urban remediation and alternative agricultural inputs.

Key Risks to Watch

• Feedstock segregation consistency and supply chain logistical risks within municipality borders.
• Biological risk of BSF colony disease outbreaks or disruptions to insect life-cycles from toxic contaminants in municipal waste.
• Execution and structural capital allocation delay risks during the phased scale-up process.

Recent Developments

On September 2, 2025, Mukka Proteins completed a strategic acquisition of a 51% stake in FABBCO Bio Cycle and Bio Protein Technology Private Limited for approximately ₹6 crore to fast-track its alternative protein capacity. On December 3, 2025, the company's joint venture with Hardik Gowda and MS Jathin Infra secured a major four-year legacy leachate treatment contract from BSWML worth ₹474.89 crore.

Closing Insight

The transformation of Mukka Proteins highlights the immense commercial potential of India's circular bio-economy. Progress in the insect protein segment and carbon offset monetization are critical factors that could materially re-rate the stock.

High Performance Trading with SAHI.